Treatment of iron deficiency anemia during pregnancy

Not Applicable

Completed

Conditions: Nutritional, Metabolic, Endocrine
Pregnancy and Childbirth
Iron deficiency anemia in pregnancy

Registration Number: PACTR201411000930108

Lead Sponsor: Faculty of Medicine

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 200

Inclusion Criteria

Pregnant women with single fetus, in the second trimester, with iron deficiency anemia (hemoglobin level <11 g/dL and ferritin levels <25 ng/dL)

Exclusion Criteria

Women with a history of anemia due to any other causes such as chronic blood loss, hemolytic anemia, and thalassemia (including thalassemic trait), severe anemia requiring blood transfusion, bronchial asthma, clinical and/or laboratory evidence of hepatic, renal, hematologic or cardiovascular abnormalities, history of peptic ulcer, hypersensitivity to iron preparations and treatment with any other iron preparation in the last one month before study entry and suspected acute infection were excluded from the study.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary efficacy parameter was the amount of increase in Hemoglobin concentration by 4 and 8 weeks, the adverse effects (the patients were asked to report any unusual or unpleasant symptoms during the study period) related to iron therapy and the patient compliance to treatment.

Secondary Outcome Measures

Name	Time	Method
Obstetric outcome in terms of gestational age at delivery, mode of delivery, maternal complications (postpartum hemorrhage and defective lactation) and neonatal outcome (neonatal weight, admission to neonatal intensive care unit and neonatal death defined as death in the first four weeks after birth) were assessed as a secondary outcome.